FORMULARY CATALOG 2022 - CRE8 Pharmacy
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
FORMULARY CATALOG 2022
WELCOME HOME
CRE8PHARMACY.COM
2
TABLE OF CONTENTS
Welcome ………………………………………………………………………….. 04
Licensed States ……………………………………………………………….. 05
Hormone Replacement Therapy ………………………………………. 06
The PCAA Advantage 07
HRT Creams & Gels 08
HRT Capsules, Tablets & Troches 09
Testosterone Therapy 10
HGH Therapy 11
Peptide Therapy ……………………………………………………………….. 12
Peptide Dosing Guide 16
Peptide Therapy Info Sheets ……………………………………………. 17
AOD-9604 18
BPC-157 19
CJC-1295 / Ipamorelin 20
Dihexa 21
DSIP (Delta Sleep Inducing Peptide) 22
Epiithalon 23
GHK-Cu 24
IGF-LR3 25
Ipamorelin 26
Kisspeptin-10 27
MK-677 (Ibutamoren) 28
PT-141 (Bremelanotide) 29
Selank 30
Semax 31
Semaglutide 32
Sermorelin Acetate 33
Zinc Thymulin 34
Peptide Therapy Mixing Instructions & Dosing Guide ………. 35
Cognitive & Mental Health ……………………………………………….. 39
Synapsin + RG3 41
Peptide Topical Creams ……………………………………………………. 42
Exclusive Organic Bio Cream 44
Weight Loss & Vitamin Therapy ………………………………………… 45
Glutathione 47
Lipotropic Formulas 48
LIV Injection 49
Semaglutide 50
Vitamin D3 51
Hair Loss Therapy ……………………………………………………………… 52
Sexual Wellness ………………………………………………………………… 54
CRE8 Vitality Nutrition ……………………………………………………… 57
CRE8RX.Online E-Prescribing Portal ………………………………… 63
Additional Peptide References ………………………………………… 65
Contact Us ……………………………………………………………………….. 67
3
WELCOME TO CRE8 PHARMACY
Located in Coral Springs, Florida, CRE8 Pharmacy is dedicated to providing the medical community with the
highest in quality pharmaceutical compounding services. We are proud to o er compounded medications for
personalized medicine to doctors across the USA. We adhere to the guidance provided under section 503A of
the Food, Drug, and Cosmetics Act (FDCA). CRE8 Pharmacy is compliant with USP chapters and for
non-sterile and sterile compounding practices. We comply with new USP guidelines for the handling of
Hazardous Drugs (HD’s).
CRE8 Pharmacy believes in o ering outstanding levels of safety and quality compounds provided with
exceptional customer service. We strive to provide the highest quality compounds to each individual patient with
interactions that elevate the pharmacy experience. Our mission is to be leaders in safety and compliance
practices for compounding pharmacies to ensure the best medications for all patients.
WE ARE SPECIALISTS
Our team brings over four decades of combined experience to the table. We have earned the reputation of
industry experts in: designing, building, training, managing and operating compounding pharmacies. Our
laboratory and clean room environments are out itted with advanced technology, enabling us to meet the ever-
increasing demands for personalized solutions in medicine. Come discover the vast options CRE8 Pharmacy can
provide for your patients!
Perfectly customized formulas! Oral Administrations (capsules, dissolving troches, liquid suspensions)!
Transdermal Applications! Suppositories and Injections (liquid, lyophilized) – start with us today!
Our team continuously works to create specialized formulations, dispense orders in a timely fashion and resolve
issues promptly.
Giving you everything a patient needs shipped in one simple order:
• Sterile & Non-Sterile Compounds
• Nutritional Supplementation
• Generic & Commercial Medications
To learn more about our services and our team we encourage you to visit www.cre8pharmacy.com.
We look forward to earning your business.
Come and discover for yourself why leading physicians across the United States trust and partner with CRE8
Pharmacy due to our authenticity, dependability, excellent customer service and competitive pricing!
Here’s to your Health and Vitality,
The CRE8 Pharmacy Team
Contact us today at 888.224.5181
In an e ort to reduce our carbon footprint, CRE8 Pharmacy
will also be releasing the pages of this document digitally.
Please consider the environment before printing it out.
We only have 1 planet, let’s take care of it!
4
ff
ff
f
ff
LICENSED STATES WE SHIP TO
VI
PR
• Alaska • Maine • Puerto Rico
• Arizona • Maryland • Rhode Island
• Colorado • Massachusetts • South Dakota
• Connecticut • Minnesota • Tennessee
• District of Columbia • Missouri • Texas
• Delaware • Nevada • Utah
• Florida • New Hampshire • Virginia
• Georgia • New Jersey • Washington
• Hawaii • New Mexico • West Virginia
• Iowa • New York • Wisconsin
• Idaho • Ohio • Wyoming
• Illinois • Oklahoma • Virgin Islands
• Indiana • Pennsylvania
Map Updated Feb. 1st, 2022
SHIPPING FEES
• Ground (Arrives Next Day within Florida) $15.00
• 2nd Day Air $24.00
• Next Day Air $40.00
• Saturday $45.00
HORMONE
REPLACEMENT
THERAPY
6
HORMONE REPLACEMENT
THERAPY
THE PCCA ADVANTAGE
As a proud member of PCCA (Professional Compounding Centers of America),
CRE8 Pharmacy has access to:
• Clinical Services team of 20+ full-time pharmacists at our disposal 24/7/365 days a year
• Formula Access - 9,400+ formulas, whenever and wherever we need them
• Exclusive Bases - compounding vehicles with unmatched performance and reliability
• Pharmacy Compounding Education — education, training and support for all sta
EXCLUSIVE BASES
70+
PCCA o ers more than 70 high-quality proprietary bases, from leading topical and transdermal technologies
to unique oral and nebulization preparations. They bring the brightest minds and the best equipment
together to create bases with industry-tested chemical compatibility and superior emulsions. For a complete
list of bases for your speci ic needs please contact one of our Physician Liaisons.
FORMULATIONS
We know that everything from the chemicals to the base to the formula to the support all add up to the inal compounded
preparation that can change a life, or even save it. That’s why The PCCA Standard doesn’t just apply to our chemicals and bases; it
applies to the formulas we develop and the science behind them, all to help PCCA members con idently and carefully compound
prescriptions for their patients.
9400+
Proprietary formulas that help
155+
FormulaPlus™ formulas with extended
45+
Bracketed formulas with
achieve positive, reproducible results beyond-use dates (BUD’s) extended BUD’s
for your patients
PCCA’s Formulation Development PCCA formulas are backed by solid These allow you to use a single formula
team creates, monitors and tests science. They have gone through and to create a number of compounds with
formulas at the request of PCCA passed stability-indicating testing and are extended BUD’s as long as the API in
members or our Clinical Services denoted in our database with the “BUD each compound is within the range of
department, and to support new Study” designation in the title and strengths listed in the formula. For
PCCA bases and APIs. They also test accompanied by the FormulaPlus™ bracketed formulas, we use a stability-
and update our formulas continually, symbol: indicating assay to test the potency of
support them with research whenever the low concentration and the high
possible, and maintain our Stability-indicating testing methods are concentration of the API(s) in the
unparalleled database so that the so precise that they are capable of not formulation over time. This establishes
latest versions are always available. only detecting the speci ic API in the the potency over time of the entire
preparation, but also the presence of range of strengths for the API.
This means that CRE8 Pharmacy has other substances, such as impurities,
access to tested, well-supported degradation products and excipients, and
compounding formulas that abide by clearly di erentiating between all of them
the latest regulations, use new and to provide an incredibly precise measure
improved technologies, and of the potency of the API over time,
incorporate the most clinically thereby verifying the stability of the
relevant bases and APIs to provide preparation.
options for patients who need them.
7
ff
ff
f
f
f
f
f
HRT CREAMS & GELS
Compounded with PCCA® Exclusive Bases & Ingredients
DESCRIPTION FORMULA COMMON STRENGTHS QTY
Bi-Estrogen Cream (E2, E3) 50/50 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) 50/50 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) PLUS 1 HORMONE 50/50 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) PLUS 1 HORMONE 50/50 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) PLUS 2 HORMONES 50/50 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) PLUS 2 HORMONES 50/50 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) PLUS 3 HORMONES 50/50 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) PLUS 3 HORMONES 50/50 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) 80/20 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) 80/20 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) PLUS 1 HORMONE 80/20 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) PLUS 1 HORMONE 80/20 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) PLUS 2 HORMONES 80/20 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) PLUS 2 HORMONES 80/20 strengths 6%+ 30 g
Bi-Estrogen Cream (E2, E3) PLUS 3 HORMONES 80/20 standard strengths 30 g
Bi-Estrogen Cream (E2, E3) PLUS 3 HORMONES 80/20 strengths 6%+ 30 g
BLT (Benzocaine / Lidocaine / Tetracaine Cream standard strengths 30 g
DHEA Cream standard strengths 30 g
Estradiol Cream standard strengths 30 g
Estradiol Cream strengths 10mg+ 30 g
Ketoprofen Cream standard strengths 30 g
LT (Lidocaine / Tetracaine Cream standard strengths 30 g
Pregnenolone Cream standard strengths 30 g
Progesterone Cream standard strengths 30 g
Progesterone Cream strengths 210mg+ 30 g
Progesterone / Testosterone Cream standard strengths 30 g
Progesterone / Testosterone Cream strengths 210mg+ / 210mg+ 30 g
Progesterone / Testosterone / Estradiol Cream standard strengths 30 g
Progesterone / Testosterone / Estradiol Cream strengths 210mg+ / 210mg+ / 10mg+ 30 g
Testosterone Cream standard strengths 30 g
Testosterone Cream strengths 210mg+ 30 g
Testosterone Cream PLUS 1 HORMONE standard strengths 30 g
Testosterone Cream PLUS 1 HORMONE strengths 210mg+ 30 g
Tri-Estrogen Cream standard strengths 30 g
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
8HRT CAPSULES, TABLETS &
TROCHES
7-Keto DHEA 10 mg Melatonin (available in SR) 2 mg
25 mg 4 mg
50 mg 6 mg
Anastrozole 0.25 mg 12 mg
0.5 mg Metformin 250 mg
0.75 mg 500 mg
Anastrozole ® 1 mg Naltrexone HCl 3 mg
Arimidex ® 1 mg 5 mg
Armour Thyroid ® 0.25 Grain (15mg) Naltrexone HCl / B12 10 / 1 mg
0.5 Grain (30mg) NP Thyroid ® 30 mg
1 Grain (60mg) 60 mg
1.5 Grain (90mg) 90 mg
2 Grain (120mg) Oxandrolone 5 mg
3 Grain (180mg) 10 mg
Bi-Estrogen (E2, E3) 1 mg 25 mg
5 mg Pregnenolone (available in SR) 10 mg
10 mg 25 mg
Chrysin 250 mg 50 mg
Clomiphene Citrate 12.5 mg 100 mg
25 mg Progesterone (available in SR) 25 mg
50 mg 50 mg
51 mg 100 mg
Cytomel (available in SR) 5 mcg 150 mg
25 mcg 200 mg
Cytomel / Anastrozole 12.5 mg / 0.125 mg Synthroid ® 25 mcg
Cytomel / Tamoxifen 12.5 mg / 10 mg 50 mcg
Danazol (available in SR) 10 mg 75 mcg
25 mg 100 mcg
DHEA (available in SR) 5 mg 112 mcg
25 mg Tamoxifen Citrate ® 10 mg
50 mg 20 mg
100 mg Thyroid (Porcine) 15 mg
DHEA / Pregnenolone 10 / 25 mg 25 mg
50 / 50 mg 45 mg
DMSA 100 mg 50 mg
Estradiol 1 mg 100 mg
2 mg
Hydrocortisone 2.5 mg
5 mg
Letrizole 2.5 mg SUBLINGUAL TROCHES
Liothyronine/Levothyroxine 2.25/9.5 mcg
4.5/19 mcg Bi-Estrogen 0-5 mg
9/38 mcg DHEA 10 mg
11/47.5 mcg 50 mg
18/76 mcg Estriol standard strengths
Levothyroxine (T4) SR 50 mcg Progesterone 25 mg
100 mcg 100 mg
Liothyronine (T3) SR 5 mcg Testosterone 10 mg
10 mcg 50 mg
50 mcg 100 mg
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
9TESTOSTERONE
THERAPY
INJECTABLES
Testosterone Cypionate (Compounded in Sesame Oil) 20mg/mL 5 mL
Testosterone Cypionate (Compounded in Sesame Oil) 50mg/mL 4 mL
Testosterone Cypionate (Compounded in Sesame Oil) 200mg/mL 4 mL
Testosterone Cypionate (Depo-Testosterone P izer) 200 mg/mL 10 mL
Testosterone Cypionate (Generic) 200 mg/mL 10 mL
Testosterone Enanthate (Compounded in Grapeseed Oil) 200 mg/mL 4 mL
Testosterone Enanthate (Brand) 200 mg/mL 5 mL
Testosterone Cypionate / Propionate (Compounded in Sesame Oil) 160 / 40 mg/mL 5 mL
SUBLINGUAL TROCHES
Testosterone 10 mg each
50 mg each
100 mg each
CREAMS & GELS
Testosterone w/Atrevis™ Gel standard strengths 30 g
Testosterone w/Atrevis™ Gel higher strengths 21%+ 30 g
Testosterone Cream standard strengths 30 g
Testosterone Cream higher strengths 21%+ 30 g
Testosterone / Chrysin Cream standard strengths 30 g
ATREVIS™ HYDROGEL
The next-generation base for testosterone delivery.
It has long been assumed that testosterone absorbs well topically from a variety of bases. However, many patients and
physicians often report problems with achieving desired testosterone levels in male patients. There are many
variables that can a ect these levels in men, and PCCA developed a new base that has proven results for testosterone delivery.
Atrevis™ Hydrogel is an advanced topical base designed speci ically to deliver testosterone
through the skin in male patients.
ADVANCED TECHNOLOGY
Atrevis uses a novel delivery system to drive testosterone through the skin, which includes its hydrogel polymer
network along with three unique, naturally derived skin-permeation enhancers. This proprietary delivery system
was developed speci ically to drive testosterone through the skin.
THE PROOF
The results of independent testing show that Atrevis Hydrogel signi icantly outperformed both a reference base (hydro-alcoholic
surfactant solution) and a competitor base. The results show that:
Atrevis™ delivered 2.73 times as much testosterone through the skin as the competitor base
Atrevis™ delivered 1.62 times as much testosterone through the skin as the hydro-alcoholic surfactant solution
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
10
ff
f
f
f
fHGH THERAPY
PRESCRIBING GUIDE
FORMAT: Lyophilized powder
STRENGTHS AVAILABLE: 5.8mg strength
NOTES: With mixing syringe reconstitute powder vial with 1.14ml of STRENGTH IN STRENGTH IN IU
bacteriostatic water (included). Inject required dose with MG (= mg x 3)
insulin syringes (not included)
5.8mg Vial 17.4 iu
INSTRUCTIONS: Click here
AVERAGE PRICE PER 1 IU OF HGH: $23.00
FORMAT: Lyophilized powder
STRENGTHS AVAILABLE: 5mg & 10mg strengths STRENGTH IN STRENGTH IN IU
NOTES: With mixing syringe reconstitute powder vial with 5ml of MG (= mg x 3)
bacteriostatic water (included). Inject required dose with
insulin syringes (not included) 5mg Vial 15 iu
INSTRUCTIONS: Click here
10mg Vial 30 iu
AVERAGE PRICE PER 1 IU OF HGH: $23.00
FORMAT: Pre- illed pens
STRENGTHS AVAILABLE: STRENGTH IN STRENGTH IN IU
5mg - dose increments of 0.025mg MG (= mg x 3)
10mg - dose increments of 0.05mg
5mg Pen 15 iu
15mg - dose increments of 0.1mg
NOTES: No mixing needed. Dial your required dose and inject. 10mg Pen 30 iu
Uni-Fine tips not included
INSTRUCTIONS: Click here 15mg Pen 45 iu
AVERAGE PRICE PER 1 IU OF HGH: $52.00
FORMAT: Pre- illed mini syringes STRENGTH IN STRENGTH IN IU
STRENGTHS AVAILABLE: MG (= mg x 3)
0.2mg, 0.4mg, 0.6mg, 0.8mg strengths (Pack of 7)
0.2mg (7pk) 0.6 iu (4.2 iu)
NOTES: No mixing needed. Remove safety cap and inject
INSTRUCTIONS: Click here 0.4mg (7pk) 1.2 iu (8.4 iu)
AVERAGE PRICE PER 1 IU OF HGH: $62.00
0.6mg (7pk) 1.8 iu (12.6 iu)
0.8mg (7pk) 2.4 iu (16.8 iu)
INJECTABLES
Genotropin Miniquick 0.2 mg 0.6iu 7pk
0.4 mg 1.2iu 7pk
0.6 mg 1.8iu 7pk
0.8 mg 2.4iu 7pk
Norditropin FlexPro Pen 5 mg 15iu Each
10 mg 30iu Each
15 mg 45iu Each
Omnitrope Vial 5.8mg 17.4iu Each
Zomacton Vial 5mg 10iu Each
10mg 30iu Each
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
11
f
fPEPTIDE
THERAPY
12PEPTIDE
THERAPY
INJECTABLES
INJECTABLE VIALS COMMON STRENGTHS
AOD-9604 600mcg/ml (10ml Vial)
BPC-157 (Lyophilized Vial) 10 mg
Bremelanotide (PT-141) w/ B6 10,000mcg/50mg/ml (2ml Vial)
CJC-1295 / Ipamorelin (Lyophilized Vial) 4/4 mg
CJC-1295 / Ipamorelin (Lyophilized Vial) 5/9 mg
DSIP (Delta Sleep Inducing Peptide) 1000mcg/ml (3ml Vial)
GHK-Cu 10,000mcg/ml (5ml Vial)
IGF-LR3 200mcg/ml (5ml Vial)
IGF-LR3 / CJC-1295 / Ipamorelin (Lyophilized Vial) 1/6.25/3.75 mg
Ipamorelin (Lyophilized Vial) 9 mg
Kisspeptin-10 1000mcg/ml (5ml Vial)
Semaglutide / BPC-157 / B6 1.25/1.25/40mg/ml (5ml Vial)
Sermorelin Acetate (Lyophilized Vial) 9 mg
Sermorelin Acetate (Lyophilized Vial) 15 mg
CAPSULES
CAPSULES COMMON STRENGTHS
BPC-157 Capsules 500mcg
1000mcg
1500mcg
Dihexa Capsule 2mg
5mg
10mg
25mg
Ibutamoren Mesylate (MK-677) Capsules 12.5mg
25mg
Ibutamoren Mesylate (MK-677) / BPC-157 Capsules 12.5mg / 1mg
Sirolimus Capsule 3mg
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
13PEPTIDE
THERAPY
SUBLINGUAL TROCHES
SUBLINGUAL TROCHES COMMON STRENGTHS
AOD-9604 250mcg
500mcg
600mcg
AOD-9604 / Ipamorelin 300/300mcg
AOD-9604 / Ipamorelin / CJC-1295 300/300/200mcg
BPC-157 300mcg
500mcg
1000mcg
CJC-1295 300mcg
500mcg
CJC-1295 / Ipamorelin 300/300mcg
500/500mcg
DSIP 200mcg
Epithalon 3mg
Epithalon / NAD 3mg/250mg
GHK-Cu 1000mcg
Ibutamoren Mesylate (MK-677) 12.5mg
25mg
Ipamorelin 300mcg
500mcg
Kisspeptin-10 200mcg
400mcg
Semaglutide 250mcg
500mcg
Sermorelin 300mcg
500mcg
Sermorelin / Ipamorelin 300/300mcg
600/300mcg
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
14PEPTIDE
THERAPY
NASAL SPRAYS
NASAL SPRAYS COMMON STRENGTHS
BPC-157 Nasal Spray 2000mcg/ml (6ml Bottle)
Bremelanotide (PT-141) w/ B6 Nasal Spray 5/25mg/ml (10ml Bottle)
IGF-LR3 300mcg/ml (6ml Bottle)
Selank Nasal Spray 7500mcg/ml (6ml Bottle)
Semax Nasal Spray 7500mcg/ml (6ml Bottle)
SUPPOSITORIES
SUPPOSITORIES COMMON STRENGTHS
BPC-157 Suppository 500mcg
1000mcg
1500mcg
TOPICAL CREAMS
TOPICAL CREAMS COMMON STRENGTHS
AOD-9604 Cream 600mcg/ml (30g)
BPC-157 Anti-In ammatory Cream 1mg/ml (30g)
BPC-157 Organic Bio-Cream 1mg/ml (15ml Pump)
BPC-157 w/ GHK-Cu Anti-In ammatory Cream 2mg/2mg/ml (30ml Pump)
Dihexa Cream 10mg/ml (15g)
10mg/ml (30g)
Dihexa Cream 20mg/ml (15g)
20mg/ml (30g)
GHK-Cu Organic Bio-Cream 2mg/g (15ml Pump)
5mg/g (15ml Pump)
GHK-Cu w/ BPC-157 Organic Bio-Cream* 2mg/2mg/ml (15ml Pump)
5mg/5mg/ml (15ml Pump)
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
15
fl
flPEPTIDE INDICATION
& DOSING GUIDE
PEPTIDE INDICATION(s) COMMONLY PRESCRIBED DOSE
AOD-9604 (6mg Vial) Weight Loss 300mcg SQ daily for 20 days
AOD-9604 500mcg Troche Weight Loss Dissolve 1 troche daily under tongue for 20 days
BPC-157 (10mg Vial) Tendon Repair + Ligaments 300mcg SQ daily
BPC-157 500mcg Capsule Gut Repair Take one capsule daily
BPC-157 1mg/g Organic Bio-Cream Facial Redness, Acne, Skin Issues Apply 1-2 pumps daily for 30 days
CJC-1295 500mcg Troche GHRP, Sleep, Energy Dissolve 1 troche under tongue nightly
CJC-1295 / Ipamorelin (4/4mg Vial) GHRP, Sleep, Energy, Recovery 200/200mcg SQ 5 days on, 2 days o
CJC-1295 / Ipamorelin (5/9mg Vial) GHRP, Sleep, Energy, Recovery 250/450mcg SQ 5 days on, 2 days o
CJC-1295 / Ipamorelin 300/300 Troche GHRP, Sleep, Energy, Recovery Dissolve 1 troche under tongue 5 days on 2 days o
DIHEXA 2mg Capsule Neurological Function Take one capsule daily
DSIP (Delta Sleep Inducing Peptide) 3ml Vial Sleep Assistance 100mcg SQ nightly as needed
EPITHALON 3mg Troche Increases Telomere Length, Sleep Dissolve 1 troche under tongue nightly
GHK-Cu 5mg/g Organic Bio-Cream Skin Elasticity, Hair Loss Apply 1-2 pumps daily for 30 days
GHK-Cu 5mg/g Hair Foam (50ml) Hair Loss Apply 1ml to scalp nightly for 30 days
GHK-Cu + BPC-157 2/2mg/g Organic Bio-Cream Skin Elasticity, Hair Loss Apply 1-2 pumps daily for 30 days
GHK-Cu 10mg/ml (5ml Vial) Skin Elasticity, Wound Healing 2000-3000mcg SQ nightly as needed
IBUTAMOREN (MK-677) 25mg Capsule IGF-1 Increase, Energy, Performance Take one capsule daily
IGF-LR3 200mcg/ml (5ml Vial) IGF-1 Increase, Energy, Muscle 30mcg SQ daily for 30 days
IGF-LR3 / CJC-1295 / Ipamorelin (1/6.25/3.75 mg) IGF-1 Increase, Energy, Muscle 40/250/150mcg SQ 6 days on, 1 day o
IPAMORELIN (9mg Vial) GHRP, Sleep, Energy 300mcg SQ daily for 30 days
IPAMORELIN 500mcg Troche GHRP, Sleep, Energy Dissolve 1 troche daily under tongue
KISSPEPTIN-10 (5mg Vial) LH Increase 100mcg SQ nightly for 30 days
PT-141 w/ B6 10,000mcg/ml (2ml vial) 0.1ml SQ injection 30 minutes to 6 hours prior to
Erectile Dysfunction, Libido
sexual activity for males (0.2ml for females)
PT-141 w/ B6 5,000mcg (10ml Nasal Spray) Erectile Dysfunction, Libido 2-4 sprays per nostril 30-60 minutes prior to sex
SELANK 7500mcg/ml (3ml Nasal Spray) Neurological Function, Anxiety 1-2 sprays intranasal daily or as needed
SEMAX 7500mcg/ml (3ml Nasal Spray) Neurological Function, Anxiety 1-2 sprays intranasal daily or as needed
SEMAGLUTIDE / BPC-157 / B6 (1.25/1.25/40mg/ml) Weight Loss 250mcg/250mcg/8mcg SQ 5 days on, 2 days o
SEMAGLUTIDE 500mcg Troche Weight Loss Dissolve 1 troche under tongue nightly
SERMORELIN (9mg Vial) GHRP, Sleep, Energy 300mcg SQ nightly for 30 days
SERMORELIN (15mg Vial) GHRP, Sleep, Energy 500mcg SQ nightly for 30 days
ZINC THYMULIN 50mcg/ml Hair Foam (50ml) Hair Loss Apply 1ml to scalp nightly for 30 days
ZINC THYMULIN w/ GHK-Cu 10mcg/5mg/ml Hair Loss Apply 1ml to scalp nightly for 30 days
Hair Dropper (30ml)
* Additional strengths and formulas available at Physician’s request. Prices subject to change without notice.
16
f
f
f
f
fPEPTIDE
THERAPY
INFO SHEETS
17AOD-9604
BENEFITS MAY INCLUDE
• Promotes lipolysis without e ecting blood sugar • Less appetite stimulation
or tissue growth • Treatment in osteoarthritis, hypercholesterolemia,
• Prompts fat release from obese fat cells bone and cartilage repair - results favored when
• Prevents lipogenesis (fat accumulation) combined with BPC-157
• Boosts the body’s metabolism
BRIEF OVERVIEW
AOD-9604 (Advanced Obesity Drug) is a synthetic peptide fragment that comprises a modi ied 15 aminoacid region of GH with a
tyrosine component to help stabilize the molecule. It was originally developed by Professor Frank Ng at Monash University in
Australia, with the intent of inding an anti-obesity drug that had the fat burning e ects of human growth hormone (HGH) without
the muscle-building e ect. Similar to GH, AOD-9604 aids weight reduction in rodent models of obesity and was originally
developed for the treatment of obesity in humans. Additionally, it does not stimulate the production of IGF-1, has positive e ects
on the di erentiation of adipose mesenchymal stem cells into bone, and was found to promote proteoglycan and collagen
production in isolated bovine chondrocytes in an in vitro study. Its positive e ects include promoting the repair of bone and
cartilage in cases of OA.
COMMONLY PRESCRIBED FORMULAS
• AOD-9604 (600mcg/ml) 10ml Vial
• AOD-9604 (600mcg/g) Anti-In lammatory Cream
• AOD-9604 (500mcg) Sublingual Troche
CLINICAL REFERENCES
1. He ernan M, et al. “The E ects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice andβ 3-AR
Knock-Out Mice”
2. Stier H, et al. “Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans” Journal of Endocrinology and Metabolism, North America (2013)
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
18
ff
ff
ff
ff
f
ff
f
ff
ff
f
ffBPC-157
BENEFITS MAY INCLUDE
• Supports cognitive performance • Ligament healing (knee, rotary)
• Supports joint health • Bene its for ulcers in the stomach
• Protects against drug-induced damage • Bene its for intestinal damage
• Restores the serotogenic transport system • May help irritable bowel disease
• Protects dopaminergic system • Promotes lipolysis
• Enhances the GABAergic system • Improves overall skin appearance
• Reverse opioid tolerance • Repairs skin barrier proteins
• Accelerated wound healing
BRIEF OVERVIEW
BPC-157, composed of 15 amino acids, is a partial sequence of body protection compound (BPC) that is discovered in and isolated
from human gastric juice. Experimentally it has been demonstrated to accelerate the healing of many di erent wounds, including
tendons, muscles, nervous system and superior healing of damaged ligaments. Those who su er from discomfort due to muscle
sprains, tears and damage may bene it from treatment with this peptide. It can also help aid skin burns to heal at a faster rate and
increase blood low to damaged tissues.
COMMONLY PRESCRIBED FORMULAS
• BPC-157 (10mg) Lyophilized Vial
• BPC-157 (500mcg) Capsule
• BPC-157 (500mcg) Sublingual Troche
• BPC-157 (500mcg) Suppository
• BPC-157 (1mg/g) Anti-In lammatory Cream
• BPC-157 (1mg/g) Organic Bio-Cream (facial)
• GHK-Cu / BPC-157 (2mg/2mg/ml) Organic Bio-Cream (facial)
CLINICAL REFERENCES
1. Cerovecki, Tomislav; Bojanic, Ivan; Brcic, Luka; Radic, Bozo; Vukoja, Ivan; Seiwerth, Sven; Sikiric, Predrag (September 2010). "Pentadecapeptide BPC 157 (PL 14736)
improves ligament healing in the rat". Journal of Orthopaedic Research. 28 (9): 1155–1161. doi:10.1002/jor.21107. ISSN 1554-527X. PMID 20225319.
2. "Stable gastric pentadecapeptide BPC 157 in trials for in lammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and
vascular response". PMID 17186181.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
19
f
f
f
f
f
f
ff
ffCJC-1295+IPAMORELIN
BENEFITS MAY INCLUDE
• Promotes lipolysis • Accelerated injury recovery
• Improves sleep quality • Improved immune system
• Increased energy • Increased protein synthesis
• Increased endurance • Increase in lean body mass
• Improved cellular repair • Increased collagen production
• Increased IGF-1 • Increase in lean body mass
• Increased bone density • Less appetite stimulation
BRIEF OVERVIEW
CJC-1295 is 30 amino acid peptide hormone that has shown promising and amazing results as a Growth Hormone Releasing
Hormone (GHRH) analog. CJC-1295 stimulates HGH secretion and can provide a steady increase of HGH with minimal e ect on
cortisol and prolactin levels. This means increased protein synthesis thus promoting growth and fat loss simultaneously.
Ipamorelin mimics ghrelin and binds to the ghrelin receptor (or GH secretagogue receptor, GHSR) in the brain, thereby selectively
stimulating the release of GH from the pituitary gland. This results in increased plasma GH levels, which would a ect many
biological processes. Unlike other GH releasing peptides, Ipamorelin only stimulates GH release in a manner very similar to that of
growth hormone releasing hormone. This combination results in a great aid for sleep, energy, stamina and recovery bene its.
COMMONLY PRESCRIBED FORMULAS
•
CJC-1295 / Ipamorelin (4/4mg) Lyophilized Vial
•
CJC-1295 / Ipamorelin (5/9mg) Lyophilized Vial
•
CJC-1295 / Ipamorelin (300/300mcg) Sublingual Troche
CLINICAL REFERENCES
1. Teichman, Sam L.; Neale, Ann; Lawrence, Betty; Gagnon, Catherine; Castaigne, Jean-Paul; Frohman, Lawrence A. (2006). "Prolonged Stimulation of Growth
Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults". The Journal of Clinical
Endocrinology & Metabolism. 91 (3): 799–805. doi:10.1210/jc.2005-1536. ISSN 0021-972X. PMID 16352683.
2. Gobburu, Jogarao V. S.; Agersø, Henrik; Jusko, William J.; Ynddal, Lars (1999).Pharmacokinetic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in
Human Volunteers". Pharmaceutical Research. 16 (9): 1412–1416. doi:10.1023/A:1018955126402. ISSN 0724-8741.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
20
ff
ff
fDIHEXA
BENEFITS MAY INCLUDE
• Improves cognitive function • Helps manage depression
• Helps in the treatment of Alzheimer’s Disease • Enhances creative thinking and social interaction
and Parkinson’s Disease • Improved heart health
• Improves long and short-term memory • Improves brain focus
BRIEF OVERVIEW
Dihexa, also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is an oligopeptide drug derived from angiotensin IV that binds
with high a inity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met. Dihexa has been found to
potently improve cognitive function in animal models of Alzheimer's disease-like mental impairment. In an assay of neurotrophic
activity, Dihexa was found to be seven orders of magnitude more potent than brain-derived neurotrophic factor. An orally active,
blood– brain barrier permeable compound was subsequently developed with the potential to treat Alzheimer’s disease and other
disorders that would bene it from augmented synaptic connectivity.
COMMONLY PRESCRIBED FORMULAS
• Dihexa (2mg) Capsule
• Dihexa (5mg) Capsule
• Dihexa (20mg/ml) Transdermal Cream (30g)
CLINICAL REFERENCES
1. Joseph W. Harding; John W. Wright; Caroline C. Benoist; Leen H. Kawas; Gary A. Wayman (3 December 2013). "Patent US 8598118 - Hepatocyte growth factor
mimics as therapeutic agents". Retrieved 11 October 2015.
2. Alene T. McCoy; Caroline C. Benoist; John W. Wright; Leen H. Kawas; Jyote Bule-Ghogare; Mingyan Zhu; Suzanne M. Appleyard; Gary A. Wayman; Joseph W.
Harding (January 2013). "Evaluation of metabolically stabilized angiotensin IV analogs as pro-cognitive/anti-dementia agents". The Journal of Pharmacology and
Experimental Therapeutics. 344 (1): 141–154. doi:10.1124/jpet.112.199497. PMC 3533412. PMID 23055539.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
21
ff
fDSIP
(DELTA SLEEP INDUCING PEPTIDE)
BENEFITS MAY INCLUDE
• Improvement on disturbed sleeping patterns • Decreased production of somatostatin production
• Improved LH and GH release • Reduction of chronic pain
• Decreased production of cortisol production • Regulation of your circadian rhythm
BRIEF OVERVIEW
DSIP (Delta sleep-inducing peptide) is a neuromodulator and natural sleep-promoting nonapeptide with many other physiologic
functions. It is predominately found in the brain and easily passes the blood-brain barrier. It has been used for the treatment of
poor sleep, pain conditions, stress-related symptoms, low testosterone (via stimulation of LH), and even sometimes as an
antioxidant and anti-cancer protein. It exhibits a pronounced stress protective action and decreases stress-induced metabolic
and functional disorders in human and animal organisms exposed to a variety of stresses. In humans, DSIP is shown to directly
impact the secretion of adrenocorticotropic hormone (ACTH), luteinizing hormone (LH) and growth hormone (GH). It may also
play a role in the regulation of circadian rhythms.
COMMONLY PRESCRIBED FORMULAS
•
DSIP - Delta Sleep Inducing Peptide (1000mcg/ml) 3ml Vial
•
DSIP - Delta Sleep Inducing Peptide (200mcg) Troche
CLINICAL REFERENCES
1. Abba J.KastinGayle A.OlsonAndrew V.SchallyDavid H.Coy, Alene T. McCoy; Caroline C. Benoist; John W. Wright; Leen H. Kawas; Jyote Bule-Ghogare; Mingyan Zhu;
Suzanne M. https://doi.org/10.1016/0166-2236(80)90060-0
2. J M Gimble , A A Ptitsyn, B C Goh, T Hebert, G Yu, X Wu, S Zvonic, X-M Shi, Z E Floyd Delta sleep-inducing peptide and glucocorticoid-induced leucine zipper:
potential links between circadian mechanisms and obesity? PMID: 19849801 https://doi.org: 10.1111/j.1467-789X.2009.00661.x
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
22EPITHALON
BENEFITS MAY INCLUDE
• Regulates cell cycle through telomerase activity • Activate gene expression and protein synthesis in
up-regulation speci ic target tissues
• Increases and restores telomere length • Activates chromatin which its primary function is
• Improves glucose tolerance and decreases insulin and packaging long DNA molecules into more compact,
triglyceride levels denser structures
• Improvement on disturbed sleeping patterns
BRIEF OVERVIEW
Epithalon (also known as Epitalon) is the synthetic version of the polypeptide Epithalamin which is naturally produced in humans.
The pineal peptide preparation is secreted in the epithalamium-epiphyseal region of the brain. It is used to regulate metabolism in
the epiphysis, increase the sensitivity of hypothalamus to its natural hormonal in luences, normalize the function of the anterior
pituitary, regulate the levels of gonadotropins and melatonin in the body. Epithalamin increases a person's resistance to emotional
stress and also acts as an antioxidant. It is a bio-regulator for the endocrine system, especially for the pineal gland, and has been
shown to lengthen telomeres in human cells. The mechanisms in Epitalon’s primary role is to increase the natural production of
telomerase, a natural enzyme that helps cells reproduce telomeres, which are the protective parts of our DNA. This allows the
replication of our DNA so the body can grow new cells and rejuvenate old ones. It reduces lipid oxidation and ROS, along with
normalizing T cell function. It seems to normalize cholesterol and uric acid, along with prolactin levels. It has shown promise in
restoring pancreatic hormone function. Epithalon can also restore and normalize melatonin levels in older patients who have lost
some pineal function due to aging.
COMMONLY PRESCRIBED FORMULAS
•
Epithalon - (3mg) Sublingual Troche
•
Epithalon / NAD - (3mg / 250mg) Sublingual Troche
•
Epithalon Nasal Spray (300mcg/ml) 6ml Bottle
CLINICAL REFERENCES
1. Christensen, K., Thinggaarda, M., McGue, M., Rexbye, H., Hjelmborg, J.B., Aviv, A., … Vaupel, J.W. (2009). Perceived age as a clinically useful biomarker of aging:
cohort study. Bio Medical Journal (online). 339:b5262.
2. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells V Kh Khavinson 1, I E Bondarev, A A Butyugov A iliationsexpand
PMID: 12937682 DOI: 10.1023/a:1025493705728
3. Khavinson VK, et al. Byulleten’ Eksperimental’noi Biologii i Meditsiny, Peptide Geroprotector from the Pituitary Gland Inhibits Rapid Aging of Elderly People: Results
of 15-Year Follow-UpVol. 151, No. 3, pp. 343- 347, March, 2011
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
23
f
f
ffGHK-CU
BENEFITS MAY INCLUDE
• Improved skin elasticity and irmness • Improves wound healing and reduce infections
• Reduces hyper-pigmentation and skin spots • Increases hair growth and follicle size
• Stimulates skin collagen • Increase production of stem cells
• Improves overall skin appearance • Bone Repair
• Reduces in lammation • Antimetastatic properties
BRIEF OVERVIEW
GHK-Cu is a tripeptide with the amino acid sequence glycyl-histidyl-lysine. It naturally occurs in human plasma. It has also been
found in saliva, and urine. In plasma the level of GHK declines as you age. This decline in the GHK-level coincides with the
noticeable decrease in regenerative capacity of an organism. GHK-Cu functions as a complex with copper stimulates collagen
production, accelerates wound healing and contraction, improves the take of transplanted skin, and also possesses anti-
in lammatory properties.
COMMONLY PRESCRIBED FORMULAS
•
GHK-Cu (5mg/ml) Organic Bio-Cream (facial)
•
GHK-Cu (5mg/ml) Hair Foam (50ml Bottle)
•
GHK-Cu / BPC-157 (2mg/2mg/ml) Organic Bio-Cream (facial)
•
GHK-Cu (10,000mcg/ml) 5ml Vial
•
Zinc Thymulin w/ GHK-Cu (10mcg/5mg/ml) Hair Foam (50ml Bottle)
•
Zinc Thymulin w/ GHK-Cu (50mcg/5mg/ml) Hair Foam (50ml Bottle)
•
Zinc Thymulin w/ GHK-Cu (10mcg/5mg/ml) Hair Dropper (30ml Bottle)
•
Zinc Thymulin w/ GHK-Cu (50mcg/5mg/ml) Hair Dropper (30ml Bottle)
CLINICAL REFERENCES
1. L. Pickart, J. H. Freedman, W. J. Loker et al., “Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells,” Nature, vol. 288, no. 5792,
pp. 715–717, 1980.
2. D. Downey, W. F. Larrabee Jr., V. Voci, and L. Pickart, “Acceleration of wound healing using glycyl-histidyl-lysine copper (II),” Surgical Forum, vol. 25, pp. 573–575,
1985.
3. H. Ehrlich, “Stimulation of skin healing in immunosuppressed rats,” in Proceedings of the Symposium on Collagen and Skin Repair, Reims, France, September 1991.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
24
f
f
fIGF-LR3
BENEFITS MAY INCLUDE
• Helps production of protein synthesis in the body • Up-regulates anti-oxidant bene its
• It regulates the storage of fat and distributes it to be used • Helps in the development of hyperplasia in muscle cells,
for the production of energy. which lead to fuller muscle tissues
• Increases lean body mass and decreases fat
• Increases the regenerative properties of the body’s nerve
tissues.
BRIEF OVERVIEW
IGF-LR3 is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1). It di ers from native IGF-1 in
that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence ("arginine 3"), and also has
an additional 13 amino acids at its N-terminus ("long"), for a total of 83 amino acids (relative to the 70 of IGF-1). The consequences
of these modi ications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very
low a inity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability. As a result, it is
approximately three times more potent than IGF-1, and possesses a signi icantly longer half-life of about 20–30 hours (relative to
IGF-1's half-life of about 12–15 hours). IGF-1 LR3 (insulin-like growth factor-1 long arginine 3) is a synthetic, modi ied construct of
insulin-like growth factor-1. Because IGF-1 LR3 does not bind to IGF-1 binding proteins very well, it remains active up to 120 times
longer than standard IGF-1. This results in improved half-life for the peptide and thus increased activity. IGF-1 LR3 enhances cell
division and growth, boosts fat metabolism, and increases muscle repair and hypertrophy by inhibiting myostatin. IGF-1 LR3
inhibits the movement of glucose into the body cells which facilitates fat burning and the use of fat in the body for the production
of energy.
COMMONLY PRESCRIBED FORMULAS
•
IGF-LR3 (200mcg/ml) 5ml Vial
•
IGF-LR3 (300mcg/ml) Nasal Spray 6ml Bottle
CLINICAL REFERENCES
1. Tomas FM, Lemmey AB, Read LC, Ballard FJ (1996). "Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when
administered by injection". J. Endocrinol. 150 (1): 77–84. doi:10.1677/joe.0.1500077. PMID 8708565.^
2. Mohan S, Baylink DJ (2002). "IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms". J. Endocrinol. 175 (1): 19–
31. doi:10.1677/joe.0.1750019. PMID 12379487.
3. ^ Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read LC, Ballard FJ (1992). "Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are
anabolic in dexamethasone-treated rats". Biochem. J. 282 ( Pt 1): 91–7. doi:10.1042/bj2820091. PMC 1130894. PMID 1371669.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
25
ff
f
f
f
ff
fIPAMORELIN
BENEFITS MAY INCLUDE
• Promotes lipolysis • Improved cellular repair
• Increased collagen production • Increased IGF-1
• Increase in lean body mass • Counteracts glucocorticoid catabolic e ects
• Improves sleep quality • Less appetite stimulation
• Increased energy • Less release of cortisol, prolactin and aldosterone
• Increased endurance
BRIEF OVERVIEW
Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and a ghrelin mimetic with growth hormone (GH) releasing activity.
Ipamorelin mimics ghrelin and binds to the ghrelin receptor (or GH secretagogue receptor, GHSR) in the brain, thereby selectively
stimulating the release of GH from the pituitary gland. This results in increased plasma GH levels, which would a ect many
biological processes. Besides its presence in the brain, GHSR can also be found in the gastrointestinal tract, heart, lung, liver,
kidney, pancreas, adipose tissue and immune cells. Unlike other GH releasing peptides, Ipamorelin only stimulates GH release in a
manner very similar to that of growth hormone releasing hormone.
COMMONLY PRESCRIBED FORMULAS
•
Ipamorelin (9mg) Lyophilized Vial
•
Ipamorelin (300mcg) Sublingual Troche
•
CJC-1295 / Ipamorelin (4/4mg) Lyophilized Vial
•
CJC-1295 / Ipamorelin (5/9mg) Lyophilized Vial
CLINICAL REFERENCES
1. Gobburu, Jogarao V. S.; Agersø, Henrik; Jusko, William J.; Ynddal, Lars (1999).Pharmacokinetic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in
Human Volunteers". Pharmaceutical Research. 16 (9): 1412–1416. doi:10.1023/A:1018955126402. ISSN 0724-8741.
2. Raun, K; Hansen, B.; Johansen, N.; Thogersen, H; Madsen, K; Ankersen, M; Andersen, P. (1998). "Ipamorelin, the irst selective growth hormone secretagogue".
European Journal of Endocrinology. 139 (5): 552–561. doi:10.1530/eje.0.1390552. ISSN 0804-4643.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
26
ff
f
ffKISSPEPTIN-10
BENEFITS MAY INCLUDE
• Evokes luteinizing hormone secretion • Reverse e ects of hypogonadotropic hypogonadism
• Increases Testosterone • Increases aldosterone production
• Increases follicle stimulating hormone • Improves cognitive function
• Increased energy • Bene icial for low libido (male & female)
BRIEF OVERVIEW
Kisspeptins are a family of peptide hormones, which have been shown to play a critical role in the regulation of the hypothalamic–
pituitary–gonadal axis, thus in luencing fertility and reproduction. In 1996, a research team at the University of Pennsylvania
(Hershey, PA, USA) irst identi ied the Kisspeptin gene (KISS1 - named after the most famous local product Hershey’s Kisses ) for its
anti-metastatic properties in malignant melanoma . Later on Kisspeptin-based studies have identi ied a role in idiopathic
hypogonadotrophic hypogonadism, hypothalamic amenorrhoea, hyperprolactinaemia, in vitro fertilisation, polycystic ovarian
syndrome and psychosexual disorders.
COMMONLY PRESCRIBED FORMULAS
•
Kisspeptin-10 (1000mcg/ml) 5ml Vial
•
Kisspeptin-10 (200mcg) Troche
•
Kisspeptin-10 (400mcg) Troche
CLINICAL REFERENCES
1. J. T. George, J. D. Veldhuis, A. K. Roseweir, C. L. Newton, E. Faccenda, R. P. Millar,* and R. A. Anderson; “Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse
Frequency in Men”; doi: 10.1210/jc.2011-0089
2. C. N. Jayasena , A. N. Comninos , J. D. Veldhuis, S. Misra, A. Abbara, C. Izzi‐Engbeaya, M. Donaldson, M. A. Ghatei, S. R. Bloom, W. S. Dhillo; “A single injection of
kisspeptin‐54 temporarily increases luteinizing hormone pulsatility in healthy women”; doi.org/10.1111/cen.12179
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
27
f
ff
f
f
f
fMK-677
(IBUTAMOREN)
BENEFITS MAY INCLUDE
• Promotes lipolysis • Increased endurance
• Increased bone density • Improved cellular repair
• Increase in lean body mass • Increased IGF-1
• Increase muscle mass • Supports cognitive performance
• Improves sleep quality • Supports joint health
• Increased energy
BRIEF OVERVIEW
Ibutamoren (MK-677) is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a
growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin. It
has been shown to increase the secretion of several hormones including GH and insulin-like growth factor 1 (IGF-1) and produces
sustained increases in the plasma levels of these hormones without a ecting cortisol levels.
COMMONLY PRESCRIBED FORMULAS
•
Ibutamoren (MK-677) 12.5mg Capsule
•
Ibutamoren (MK-677) 25mg Capsule
•
Ibutamoren (MK-677) 25mg Troche
CLINICAL REFERENCES
1. Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DB, Cheng K, Chan WW, Butler B, Hickey G (July 1995). "Design and biological activities of
L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue". Proceedings of the National Academy of Sciences of the United States of America. 92
(15): 7001–5. doi:10.1073/pnas.92.15.7001. PMC 41459.
2. Chapman IM, Pescovitz OH, Murphy G, Treep T, Cerchio KA, Krupa D, Gertz B, Polvino WJ, Skiles EH, Pezzoli SS, Thorner MO (October 1997). "Oral administration of
growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-de icient adults". The Journal of Clinical
Endocrinology and Metabolism. 82 (10): 3455–63. doi:10.1210/jc.82.10.3455. PMID 9329386.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
28
ff
fPT-141
(BREMELANOTIDE)
BENEFITS MAY INCLUDE
• HSDD (hypoactive sexual desire disorder) in • Bene icial for ED (erectile dysfunction)
premenopausal women • Helps enhance sexual satisfaction
• Bene icial for low libido (male & female) • Skin pigmentation (sunless tanning agent)
• Increase energy
BRIEF OVERVIEW
PT-141 (Bremelanotide) is a synthetic peptide developed from Melanotan 2 (MT-II). PT-141 is used for the treatment of erectile
dysfunction or impotence in men and HSDD (hypoactive sexual desire disorder) in women. PT-141 is a peptide that was originally
developed as a sunless tanning agent. It is a melanocyte stimulating hormone (MSH) that a ects sexual arousal, aiding enhanced
libido levels and penile erections. Unlike all PDES inhibitors, PT-141 does not target the vascular system. Instead, it acts on the
nervous system via activation of neurons in the hypothalamus to increase sexual desire.
COMMONLY PRESCRIBED FORMULAS
• Bremelanotide (PT-141) 10,000mcg/ml w/ B6 50mg/ml - 2ml Vial
• Bremelanotide (PT-141) w/B6 (5/25mg/ml) Nasal Spray 10ml Bottle
CLINICAL REFERENCES
1. Shadiack AM, Sharma SD, Earle DC, Spana C, Hallam TJ. 2007;7(11):1137-44. Melanocortins in the treatment of male and female sexual dysfunction.
2. Rosen RC1, Diamond LE, Earle DC, Shadiack AM, Molinoff PB 2004 Apr;16(2):135-42. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of
subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
29
f
f
ffSELANK
BENEFITS MAY INCLUDE
• Superior learning aptitude and memory processes • Better antiviral functioning without any adverse side
• Better sensory awareness e ects
• Improved curiosity • Improved cerebral energy
• Enhanced mental concentration • Better and steady mood as well as feelings of grati ication
• Regulation of the activities of noradrenergic and and happiness.
serotonergic brain systems
• Decreased anxiety and stress levels
BRIEF OVERVIEW
Selank is a heptapeptide which is a derivative of tetra-peptide Tuftsin. The human body produces Tuftsin naturally which comes
with a broad range of bene its. The Institute of Molecular Genetics of the Russian Academy of Science initially synthesized Selank
during the late 1990’s. Stage III clinical tests were quite successful in Russia. It is one of the latest substances used for its many
anti-anxiety (anxiolytic) e ects. Selank is a precursor to the tetrapeptide known as Tuftsin. This tetrapeptide can e iciently
improve and transform your immune system.
COMMONLY PRESCRIBED FORMULAS
• Selank (7500mcg/ml) Nasal Spray 6ml Bottle
CLINICAL REFERENCES
1. Uchakina, O. N.; Uchakin, P. N.; Miasoedov, N. F.; Andreeva, L. A.; Shcherbenko, V. E.; Mezentseva, M. V.; Gabaeva, M. V.; Sokolov, O. U.; Zozulia, A. A.; Ershov, F. I.
(2008). "Immunomodulatory e ects of selank in patients with anxiety-asthenic disorders". Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova. 108 (5): 71–75. PMID
18577961.
2. Semenova, T. P.; Kozlovskiĭ, I. I.; Zakharova, N. M.; Kozlovskaia, M. M. (2009). "Comparison of the e ects of selank and tuftsin on the metabolism of serotonin in the
brain of rats pretreated with PCPA". Eksperimental'naia i klinicheskaia farmakologiia. 72 (4): 6–8. PMID 19803361.
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
30
ff
ff
ff
f
f
ff
ffSEMAX
BENEFITS MAY INCLUDE
• Enhanced mental concentration • Improved Glaucoma Optic Neuropathy
• Increased attention and short-term memory • Helpful in the treatment of ADHD
• Increased brain BDNF levels • Nootropic (cognitive-enhancing) e ects
• Reduces breakdown of enkephalins • Neuroprotection: may help protect the brain from
• Improved Non-proliferative Diabetic Neuropathy various types of stress and damage
• Can help during recovery from Stroke/Hypoxia • Decreased anxiety and stress levels
BRIEF OVERVIEW
Semax is a peptide known best for its nootropic, neurogenic/neurorestorative and neuroprotective properties. It is a modi ied
snippet of a hormone called adrenocorticotropic hormone (ACTH). Semax is the basis for a number of drugs that are used in
clinical practice for the treatment of CNS diseases (ischemic brain stroke, dys-circulatory encephalopathy, optic nerve atrophy,
etc.) and to enhance adaptability under extreme conditions in healthy persons. Heptapeptide SEMAX (MEHFPGP) is the analogue
of ACTH (4-10) that has prolonged neurotropic activity and thus is a good candidate for medical therapy. Currently this peptide is
successfully used in treatment of patients with pathologies related to brain circulation dysfunction and with di erent intellectual-
amnestic problems of the CNS. Doctors have prescribed it for many conditions like anxiety, memory improvement, ischemic
events, stroke, nerve regeneration, ADHD, opioid withdrawal, and even chronic diseases such as ALS, Parkinson’s, and Alzheimer’s.
COMMONLY PRESCRIBED FORMULAS
• Semax (7500mcg/ml) Nasal Spray 6ml Bottl
CLINICAL REFERENCES
1. Shih-Jen Tsai - Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-de icit hyperactivity disorder and Rett
syndrome PMID: 16996699 DOI: 10.1016/j.mehy.2006.07.017
2. G S Polunin, S M Nurieva, D L Baiandin, N L Sheremet, L A Andreeva - Evaluation of therapeutic e ect of new Russian drug semax in optic nerve disease] PMID:
10741256
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
31
ff
e
ff
f
ff
fSEMAGLUTIDE
BENEFITS MAY INCLUDE
• Promotes lipolysis • Lowers BMI
• Improves blood sugar levels in adults with Type 2 diabetes • Plaque hemorrhage is reduced
• Lowers A1C • Helps pancreatic insulin release to lower glucose levels in
• Cardiovascular bene its - lowers risk of cardiovascular the bloodstream
events such as heart attacks & strokes
BRIEF OVERVIEW
Semaglutide is a glucagon-like peptide (GLP-1) analog as an FDA approved treatment method for improving glycemic control in
patients with Type 2 diabetes. It increases insulin secretion, which is good for diabetes. At higher doses, it can act on centers in
the brain and help suppress appetite. Used in conjunction with lifestyle changes and a reduced-calorie diet, Semaglutide can
have a very successful outcome with weight loss and lowering high blood pressure. Studies show that Semaglutide can reduce
appetite, improved control of eating, and reduce food cravings in addition to improved glycemic control. Some studies show
negative side e ects that may include nausea, diarrhea and even vomiting. The inclusion of BPC-157 and Pyridoxine (B6) may help
decrease nausea e ect.
COMMONLY PRESCRIBED FORMULAS
• Semaglutide / BPC-157 / B6 (1.25mg/1.25mg/40mg/ml) - 5ml Vial
• Semaglutide (250mcg) Sublingual Troche
• Semaglutide (500mcg) Sublingual Troche
CLINICAL REFERENCES
1. John P.H. Wilding, D.M., Rachel L. Batterham, M.B., B.S., Ph.D., Salvatore Calanna, Ph.D., Once-Weekly Semaglutide in Adults with Overweight or Obesity DOI:
10.1056/NEJMoa2032183
2. Robert F. Kushner 1, Salvatore Calanna2, Melanie Davies3,4,5, Dror Dicker6,7, W. Timothy Garvey 8,9, Bryan Goldman2, Ildiko Lingvay10,11, Mette Thomsen2, Thomas
A. Wadden12, Sean Wharton 13, John P.H. Wilding14, and Domenica Rubino15 - Semaglutide 2.4 mg for the Treatment of Obesity:
3. Yuko Tashiro, Kengo Sato, Takuya Watanabe, Kyoko Nohtomi, Michishige Terasaki, Masaharu Nagashima, Tsutomu Hirano, A glucagon-like peptide-1 analog
liraglutide suppresses macrophage foam cell formation and atherosclerosis, Peptides,Volume 54, 2014, Pages 19-26, ISSN 0196-9781,
These statements have not been evaluated by the Food and Drug Administration. These medications are not intended to diagnose, treat, cure or prevent any disease. Additional references available.
32
ff
ff
fYou can also read
